Medication Adherence Monitoring With Real-Time Sensor Analytics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Medication adherence is a significant issue in the healthcare system, with patients often failing to take prescribed medications due to complex regimens, confusion, and side effects, leading to substantial health and economic costs, and traditional metrics like MPR fail to account for lost medications or distribution to third parties.

Innovation Solution

The Arthur system uses real-time medication adherence (RMA) monitoring through electronic devices, providing personalized schedules, augmented reality instructions, and alerts, and leveraging blockchain technology for secure data exchange to improve adherence tracking and prediction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional medication possession ratio (MPR) metrics are used to monitor adherence, then the system is simple to implement, but it fails to account for lost medication, patient non-adherence, or medication distribution to third parties

Engineering Contradiction:
Improveadherence monitoring accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the adherence monitoring process into multiple components: electronic monitoring devices attached to medication containers, mobile applications for data collection, blockchain technology for secure data storage, and analytics platforms for interpretation. This segmentation allows each component to specialize in specific functions, improving overall measurement precision while distributing system complexity across multiple manageable subsystems.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces electronic monitoring devices as intermediaries between the medication and the patient. These devices capture data about medication handling events (opening, closing, dispensing) and transmit this information through mobile applications to blockchain-based storage systems. This intermediary layer enables precise tracking of medication status without requiring direct patient reporting, thereby improving adherence measurement accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If real-time medication adherence (RMA) monitoring through electronic devices is implemented, then adherence tracking accuracy improves, but device complexity and implementation costs increase

Engineering Contradiction:
Improvereal-time adherence detection accuracyVSAvoidelectronic monitoring system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent designs electronic monitoring devices with multi-functionality: they track medication container status, detect opening/closing events, store data locally, and communicate with mobile applications. The mobile applications themselves serve multiple functions including data collection, blockchain interaction, patient education, and provider communication. This universality reduces the need for separate specialized devices, managing complexity while maintaining high measurement precision.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The monitoring system operates largely autonomously: electronic devices automatically detect and record medication handling events without patient intervention, mobile applications automatically synchronize data with blockchain networks, and the system generates adherence reports without manual compilation. This self-service capability improves real-time detection accuracy while reducing the operational complexity burden on healthcare providers and patients.

Inventive Principle:
Principle #25Self-service

3Reliability

If blockchain technology is used for secure data exchange, then data security and patient privacy are enhanced, but system complexity and computational requirements increase

Engineering Contradiction:
Improvedata securityVSAvoidblockchain implementation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces a layered architecture where blockchain technology serves as a secure intermediary layer for data storage and exchange. Mobile applications act as intermediaries between the electronic monitoring devices and the blockchain network, handling complex cryptographic operations and data formatting. This intermediary approach allows blockchain to provide enhanced data security while shielding end users from its computational complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent extracts the most computationally intensive blockchain operations (cryptographic key management, consensus participation, smart contract execution) and performs them on dedicated servers or cloud infrastructure rather than on patient-facing devices. This extraction allows the system to leverage blockchain's security benefits while minimizing the computational burden on mobile devices and electronic monitoring components.

Inventive Principle:
Principle #2Taking out (Extraction)

4Ease of operation

If personalized medication schedules and augmented reality instructions are provided, then patient adherence improves, but system complexity and development costs increase

Engineering Contradiction:
Improvepatient adherenceVSAvoidsoftware platform complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent implements personalized medication schedules that are prepared in advance based on patient profiles, treatment plans, and adherence history. Augmented reality instructions are pre-rendered and stored in the system, ready to be activated when patients need them. This preliminary preparation reduces real-time computational requirements and allows the system to provide personalized guidance without excessive complexity during actual medication administration moments.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses augmented reality to create virtual copies of physical medication containers and instructions, overlaying digital information onto the physical world. Instead of requiring complex physical instruction manuals or multiple device interactions, the system projects simplified visual guidance directly onto the medication container or surrounding area. This copying approach enhances ease of operation by making instructions more accessible while keeping the underlying software architecture manageable.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20260038664A1Intelligent monitoring, interactive, and wireless internet connected medication adherence, analytics, and database solution
Publication Date: 2026.02.05 DAYA MEDICALS INC CANADA
  • US20260038664A1 patent drawing
  • US20260038664A1 patent drawing
  • US20260038664A1 patent drawing

AI summary

Method and devices for a medication adherence platform including machine-learning analytics platform, and real-time pharmaceutical and consumer product fulfillment platform are provided. A device can comprise a sensor for sensing a medicine container or medicine, a database for storing patient related data, a computer readable medium for storing a patient treatment calendar, causing a patient's electronic device to transmit an alert based upon an event logged onto the patient treatment calendar determine medication adherence, storing data in the database, transmitting treatment-based information to the patient's device, and establishing an electronic communication channel between the patient and a healthcare professional.